Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Relationship between gender and survival in a real-life cohort of patients with COPD.

Zysman M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Surpas P, Deslée G, Perez T, Le Rouzic O, Jebrak G, Chanez P, Paillasseur JL, Caillaud D, Roche N; Initiatives BPCO scientific committee and investigators.

Respir Res. 2019 Aug 22;20(1):191. doi: 10.1186/s12931-019-1154-3.

2.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.

Perez T, Deslée G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, Escamilla R, Jebrak G, Chanez P, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Paillasseur JL, Roche N; Initiatives BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 2;14:1399-1410. doi: 10.2147/COPD.S188412. eCollection 2019.

3.

Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome.

Brugière O, Roux A, Le Pavec J, Sroussi D, Parquin F, Pradère P, Dupin C, Bunel V, Mourin G, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Mal H, Suberbielle C, Gautreau C, Caillat-Zucman S, Cazes A, Thabut G, Taupin JL.

Eur Respir J. 2018 Aug 23;52(2). pii: 1701898. doi: 10.1183/13993003.01898-2017. Print 2018 Aug.

PMID:
29976654
4.

Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient.

Brugière O, Cazes A, Champion L, Debray MP, Mourin G, Crestani B, Sroussi D, Bunel V, Jebrak G, Dauriat G, Castier Y, Mordant P, Lortat-Jacob B, Jean-Baptiste S, Bouadma L, Mal H, Thabut G.

Transplantation. 2018 Jun;102(6):e255-e256. doi: 10.1097/TP.0000000000002153. No abstract available.

PMID:
29509571
5.

Smoking-Related Interstitial Fibrosis: Evidence of Radiologic Regression with Advancing Age and Smoking Cessation.

Fabre A, Treacy A, Lavelle LP, Narski M, Faheem N, Healy D, Dodd JD, Keane MP, Egan JJ, Jebrak G, Mal H, Butler MW.

COPD. 2017 Dec;14(6):603-609. doi: 10.1080/15412555.2017.1378631. Epub 2017 Oct 18.

PMID:
29043847
6.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.

Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1819-1824. doi: 10.2147/COPD.S129787. eCollection 2017.

7.

[Changing patterns of medication prescription for COPD patients in France. Impact of long-acting muscarinic antagonists' availability].

Jébrak G, Burgel PR, Caillaud D, Deslée G, Brinchault G, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Pinet C, Perez T, Paillasseur JL, Roche N; pour le groupe Initiatives BPCO.

Rev Mal Respir. 2017 May;34(5):535-543. doi: 10.1016/j.rmr.2017.02.006. Epub 2017 May 31. French.

PMID:
28578989
8.

Management of acute exacerbations of chronic obstructive pulmonary disease (COPD). Guidelines from the Société de pneumologie de langue française (summary).

Jouneau S, Dres M, Guerder A, Bele N, Bellocq A, Bernady A, Berne G, Bourdin A, Brinchault G, Burgel PR, Carlier N, Chabot F, Chavaillon JM, Cittee J, Claessens YE, Delclaux B, Deslée G, Ferré A, Gacouin A, Girault C, Ghasarossian C, Gouilly P, Gut-Gobert C, Gonzalez-Bermejo J, Jebrak G, Le Guillou F, Léveiller G, Lorenzo A, Mal H, Molinari N, Morel H, Morel V, Noel F, Pégliasco H, Perotin JM, Piquet J, Pontier S, Rabbat A, Revest M, Reychler G, Stelianides S, Surpas P, Tattevin P, Roche N.

Rev Mal Respir. 2017 Apr;34(4):282-322. doi: 10.1016/j.rmr.2017.03.034. Epub 2017 May 25.

PMID:
28552256
9.

[The effects of inhaled steroids withdrawal in COPD].

Jebrak G, Honore I, Serrier P, Dumoulin J, Terrioux P, Soyez F, Maurer C, Mangiapan G, Febvre M, Couderc LJ, Braun JM, Chinet T.

Rev Mal Respir. 2017 Oct;34(8):820-833. doi: 10.1016/j.rmr.2016.10.880. Epub 2017 May 12. Review. French.

PMID:
28506728
10.

[Appropriate investigations during an acute COPD exacerbation requiring hospitalization].

Jébrak G.

Rev Mal Respir. 2017 Apr;34(4):375-381. doi: 10.1016/j.rmr.2017.03.015. Epub 2017 May 10. French. No abstract available.

PMID:
28499638
11.

Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series.

Philippot Q, Cazes A, Borie R, Debray MP, Danel C, Hurtado Nedelec M, Boudjemaa S, Sroussi D, Dupin C, Mal H, Dauriat G, Jean-Baptiste S, Jebrak G, Castier Y, Mordant P, Thabut G, Brugière O.

Eur Respir J. 2017 Feb 23;49(2). pii: 1601369. doi: 10.1183/13993003.01369-2016. Print 2017 Feb. No abstract available.

12.

Impact of current cough on health-related quality of life in patients with COPD.

Deslee G, Burgel PR, Escamilla R, Chanez P, Court-Fortune I, Nesme-Meyer P, Brinchault-Rabin G, Perez T, Jebrak G, Caillaud D, Paillasseur JL, Roche N.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 13;11:2091-2097. eCollection 2016.

13.

Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?

Caillaud D, Chanez P, Escamilla R, Burgel PR, Court-Fortune I, Nesme-Meyer P, Deslee G, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N; Initiatives BPCO scientific committee and investigators.

Allergy. 2017 Jan;72(1):137-145. doi: 10.1111/all.13004. Epub 2016 Sep 27.

PMID:
27501862
14.

[The place of inhaled corticosteroids in COPD].

Chinet T, Dumoulin J, Honore I, Braun JM, Couderc LJ, Febvre M, Mangiapan G, Maurer C, Serrier P, Soyez F, Terrioux P, Jebrak G.

Rev Mal Respir. 2016 Dec;33(10):877-891. doi: 10.1016/j.rmr.2015.11.009. Epub 2016 Jan 29. Review. French.

PMID:
26831345
15.

[COPD: Patients speak to doctors. Survey from the Fédération française des associations et amicales de malades insuffisants ou handicapés respiratoires (FFAAIR)].

Jébrak G, Vicaire M, Murez A.

Rev Mal Respir. 2015 May;32(5):500-12. doi: 10.1016/j.rmr.2014.08.012. Epub 2014 Nov 5. French.

PMID:
25534551
16.

Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment.

Roche N, Jebrak G, Caillaud D, Deslée G, Brinchault G, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Pinet C, Carré P, Paillasseur JL, Perez T, Burgel PR; Initiatives BPCO scientific committee.

Eur Respir J. 2015 Jan;45(1):260-2. doi: 10.1183/09031936.00131614. Epub 2014 Oct 30. No abstract available.

17.

[French Pulmonary Medicine Society. Guidelines for clinical practice. Management of COPD. Update 2012: Pulmonary function tests. Full length text].

Perez T, Garcia G, Roche N, Bautin N, Chambellan A, Chaouat A, Court-Fortune I, Delclaux B, Guenard H, Jebrak G, Orvoen-Frija E, Terrioux P; French Pulmonary Medicine Society.

Rev Mal Respir. 2014 Mar;31(3):263-94. doi: 10.1016/j.rmr.2013.11.007. Epub 2014 Jan 14. Review. French. No abstract available.

PMID:
24680119
18.

Impact of gender on COPD expression in a real-life cohort.

Roche N, Deslée G, Caillaud D, Brinchault G, Court-Fortune I, Nesme-Meyer P, Surpas P, Escamilla R, Perez T, Chanez P, Pinet C, Jebrak G, Paillasseur JL, Burgel PR; INITIATIVES BPCO Scientific Committee.

Respir Res. 2014 Feb 17;15:20. doi: 10.1186/1465-9921-15-20.

19.

[Société de pneumologie de langue française. Guidelines for clinical practice. Management of COPD. Update 2012: Pulmonary function tests (Summary)].

Perez T, Garcia G, Roche N, Bautin N, Chambellan A, Chaouat A, Court-Fortune I, Delclaux B, Guenard H, Jebrak G, Orvoen-Frija E, Terrioux P; Societe de pneumologie de langue francaise.

Rev Mal Respir. 2014 Jan;31(1):85-90. doi: 10.1016/j.rmr.2013.10.642. Epub 2014 Jan 6. French. No abstract available.

PMID:
24461450
20.

Real-life use of inhaled corticosteroids in COPD patients versus the GOLD proposals: a paradigm shift in GOLD 2011?

Burgel PR, Deslée G, Jebrak G, Brinchault G, Caillaud D, Chanez P, Court-Fortune I, Escamilla R, Nesme-Meyer P, Paillasseur JL, Perez T, Roche N; Initiatives BPCO scientific committee.

Eur Respir J. 2014 Apr;43(4):1201-3. doi: 10.1183/09031936.00162313. Epub 2013 Oct 31. No abstract available.

21.

Neural mechanisms underlying breathing complexity.

Hess A, Yu L, Klein I, De Mazancourt M, Jebrak G, Mal H, Brugière O, Fournier M, Courbage M, Dauriat G, Schouman-Clayes E, Clerici C, Mangin L.

PLoS One. 2013 Oct 3;8(10):e75740. doi: 10.1371/journal.pone.0075740. eCollection 2013.

22.

[End of life in COPD: the dead zone …].

Jébrak G, Jousse J.

Rev Mal Respir. 2012 Nov;29(9):1073-4. doi: 10.1016/j.rmr.2012.09.013. Epub 2012 Oct 15. French. No abstract available.

PMID:
23200576
23.

Impact of comorbidities on COPD-specific health-related quality of life.

Burgel PR, Escamilla R, Perez T, Carré P, Caillaud D, Chanez P, Pinet C, Jebrak G, Brinchault G, Court-Fortune I, Paillasseur JL, Roche N; INITIATIVES BPCO Scientific Committee.

Respir Med. 2013 Feb;107(2):233-41. doi: 10.1016/j.rmed.2012.10.002. Epub 2012 Oct 23.

24.

Association between occupational exposure and the clinical characteristics of COPD.

Caillaud D, Lemoigne F, Carré P, Escamilla R, Chanez P, Burgel PR, Court-Fortune I, Jebrak G, Pinet C, Perez T, Brinchault G, Paillasseur JL, Roche N; initiative BPCO Scientific Committee.

BMC Public Health. 2012 Apr 26;12:302. doi: 10.1186/1471-2458-12-302.

25.

[Treatment of distal airways involvement in COPD].

Devillier P, Jebrak G, Morel H, Chinet T, Didier A, Roche N.

Rev Mal Respir. 2011 Dec;28(10):1340-56. doi: 10.1016/j.rmr.2011.08.005. Epub 2011 Nov 6. Review. French.

PMID:
22152941
26.

Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly.

Puisieux F, D'Andrea C, Baconnier P, Bui-Dinh D, Castaings-Pelet S, Crestani B, Desrues B, Ferron C, Franco A, Gaillat J, Guenard H, Housset B, Jeandel C, Jebrak G, Leymarie-Saddles A, Orvoen-Frija E, Piette F, Pinganaud G, Salle JY, Strubel D, Vernejoux JM, de Wazières B, Weil-Engerer S; Intergroupe PneumoGériatrie SPLF–SFGG placé sous l’égide de la Société de pneumologie de langue française (SPLF) et de la Société française de gériatrie et gérontologie (SFGG).

Rev Mal Respir. 2011 Oct;28(8):e76-93. doi: 10.1016/j.rmr.2011.09.007. Epub 2011 Oct 22. Review.

PMID:
22099417
27.

Update on the roles of distal airways in COPD.

Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, de Blic J, Devillier P, Deschildre A, Didier A, Garcia G, Jebrak G, Laurent F, Morel H, Perez T, Pilette C, Roche N, Tillie-Leblond I, Verbanck S, Dusser D.

Eur Respir Rev. 2011 Mar;20(119):7-22. doi: 10.1183/09059180.10010610. Review. Erratum in: Eur Respir Rev. 2011 Jun;20(120):123.

28.

Impact of previous cardiovascular disease on the outcome of lung transplantation.

Plantier L, Skhiri N, Biondi G, Jebrak G, Himbert D, Castier Y, Lesèche G, Mal H, Thabut G, Fournier M.

J Heart Lung Transplant. 2010 Nov;29(11):1270-6. doi: 10.1016/j.healun.2010.05.010. Epub 2010 Jul 1.

PMID:
20580260
29.

[COPD routine management in France: are guidelines used in clinical practice?].

Jebrak G; Initiatives BPCO.

Rev Mal Respir. 2010;27(1):11-8. doi: 10.1016/j.rmr.2009.08.002. Epub 2009 Dec 30. French.

PMID:
20146947
30.

Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis.

Thabut G, Christie JD, Ravaud P, Castier Y, Dauriat G, Jebrak G, Fournier M, Lesèche G, Porcher R, Mal H.

Ann Intern Med. 2009 Dec 1;151(11):767-74. doi: 10.7326/0003-4819-151-11-200912010-00004.

PMID:
19949142
31.

[Swallowing disorders, pneumonia and respiratory tract infectious disease in the elderly].

Puisieux F, D'andrea C, Baconnier P, Bui-Dinh D, Castaings-Pelet S, Crestani B, Desrues B, Ferron C, Franco A, Gaillat J, Guenard H, Housset B, Jeandel C, Jebrak G, Leymarie-Selles A, Orvoen-Frija E, Piette F, Pinganaud G, Salle JY, Strubel D, Vernejoux JM, De Wazières B, Weil-Engerer S.

Rev Mal Respir. 2009 Jun;26(6):587-605. French.

PMID:
19623104
32.

Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients.

Dauriat G, Mal H, Jebrak G, Brugière O, Castier Y, Camuset J, Marceau A, Taillé C, Lesèche G, Fournier M.

Int J Chron Obstruct Pulmon Dis. 2006;1(2):201-6.

33.

Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics.

Colombat M, Mal H, Groussard O, Capron F, Thabut G, Jebrak G, Brugière O, Dauriat G, Castier Y, Lesèche G, Fournier M.

Hum Pathol. 2007 Jan;38(1):60-5. Epub 2006 Aug 1.

PMID:
16949908
34.

Needle aspiration as first-line management of primary spontaneous pneumothorax.

Camuset J, Laganier J, Brugière O, Dauriat G, Jebrak G, Thabut G, Fournier M, Mal H.

Presse Med. 2006 May;35(5 Pt 1):765-8.

PMID:
16710143
35.

[Management of acute dyspnea].

Jébrak G.

Presse Med. 2004 Jun 5;33(10):693-4. French. No abstract available.

PMID:
15257244
36.

Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival.

Brugière O, Pessione F, Thabut G, Mal H, Jebrak G, Lesèche G, Fournier M.

Chest. 2002 Jun;121(6):1883-9.

PMID:
12065353
37.

[Fibrinolysis in pulmonary embolism].

Thabut G, Jebrak G.

Presse Med. 2001 Oct 20;30(30):1501-6. Review. French.

PMID:
11712211
38.

Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure.

Stern JB, Mal H, Groussard O, Brugière O, Marceau A, Jebrak G, Fournier M.

Chest. 2001 Jul;120(1):213-9.

PMID:
11451841
39.

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation.

Thabut G, Brugière O, Lesèche G, Stern JB, Fradj K, Hervé P, Jebrak G, Marty J, Fournier M, Mal H.

Transplantation. 2001 May 15;71(9):1295-300.

PMID:
11397965
40.

[Polyarthralgia-arthritis syndrome during rifabutin treatment (letter)].

Curino C, Bakhatar A, Jébrak G, Brugière O, Dautzenberg B, Fournier M.

Presse Med. 2000 Sep 30;29(28):1563. French. No abstract available.

PMID:
11072375
41.

[Increased dosage of inhaled corticosteroids or addition of salmeterol in symptomatic asthma].

Jébrak G.

Presse Med. 2000 Sep 23;29(27):1512-3. French. No abstract available.

PMID:
11045121
42.

[Corticosteroid therapy of non-asthmatic chronic obstructive bronchopneumopathies].

Jébrak G, Pichot-Vérité MH, Marceau A, Rullon I.

Presse Med. 2000 Sep 16;29(16):1479-87. Review. French.

PMID:
11039096
43.

[Corticosteroid therapy in obstructive lung diseases. Too much in COPD, not enough in asthma...].

Jébrak G.

Presse Med. 2000 Sep 16;29(16):1467-8. French. No abstract available.

PMID:
11039094
44.

[Corticosteroid therapy and chronic obstructive bronchopneumopathies: the ISOLDE study].

Jébrak G.

Presse Med. 2000 Sep 16;29(16):1461-2. French. No abstract available.

PMID:
11039090
45.

[Impact of Chlamydia pneumoniae infections on asthma].

Jébrak G, Brugière O, Uffredi ML.

Presse Med. 2000 Sep 9;29(25):1425-31. Review. French.

PMID:
11036520
46.

Morbidity and mortality related to the native lung in single lung transplantation for emphysema.

Mal H, Brugière O, Sleiman C, Rullon I, Jebrak G, Groussard O, Reffas T, Stern JB, Lesèche G, Fournier M.

J Heart Lung Transplant. 2000 Feb;19(2):220-3.

PMID:
10703700
47.

[Treatment with inhaled budesonide for patients with mild obstructive lung diseases who continue to smoke: long-term benefits].

Jébrak G.

Presse Med. 1999 Nov 20;28(36):1986-7. French. No abstract available.

PMID:
10599265
48.

[Are there criteria which make it possible to predict survival after deep venous thrombosis and pulmonary embolism?].

Jébrak G.

Presse Med. 1999 May 22-29;28(19):1019-20. French. No abstract available.

PMID:
10379352
49.

[Purulent pleurisy and empyema. With the exception of pleural tuberculosis].

Jébrak G, Pointet P, Pichot MH.

Presse Med. 1998 Nov 28;27(37):1924-31. Review. French.

PMID:
9858971
50.

[Leukotriene receptor antagonist effective in chronic asthma].

Jébrak G.

Presse Med. 1998 Nov 14;27(35):1795. French. No abstract available.

PMID:
9850698

Supplemental Content

Loading ...
Support Center